NTRA
Natera, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$325.95
−0.52%0
Insider buys (3m)
125
Insider sells (3m)
-$65.8M
Net value (3m)
+51.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,400 | $321 |
| Sep 3, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 600 | $322 |
| Sep 3, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,000 | $320 |
| Sep 3, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 15,160 | $327 |
| Sep 3, 2026 | Chapman Steven Leonard · director, officer: CEO AND PRESIDENT | Sale | 1,698 | $321 |
| Aug 28, 2026 | Fesko John · officer: PRESIDENT, CHIEF BUS. OFFICER | A-Award | 20,000 | $0.00 |
| Aug 28, 2026 | Fesko John · officer: PRESIDENT, CHIEF BUS. OFFICER | Sale | 6,517 | $322 |
| Aug 14, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 6,000 | $325 |
| Aug 7, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 850 | $314 |
| Aug 7, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 400 | $310 |
| Aug 7, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 5,111 | $317 |
| Aug 7, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 900 | $313 |
| Aug 7, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 200 | $318 |
| Aug 7, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 100 | $308 |
| Aug 7, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 600 | $315 |
| Aug 7, 2026 | Rabinowitz Matthew · director, officer: EXECUTIVE CHAIRMAN | Sale | 2,000 | $321 |
| Aug 7, 2026 | Sheena Jonathan · director, other: CO-FOUNDER | Sale | 489 | $321 |
| Aug 5, 2026 | Chapman Steven Leonard · director, officer: CEO AND PRESIDENT | Sale | 80 | $265 |
| Aug 5, 2026 | Chapman Steven Leonard · director, officer: CEO AND PRESIDENT | Sale | 612 | $268 |
| Aug 5, 2026 | Chapman Steven Leonard · director, officer: CEO AND PRESIDENT | Sale | 676 | $264 |
| Aug 5, 2026 | Fesko John · officer: PRESIDENT, CHIEF BUS. OFFICER | Sale | 295 | $268 |
| Aug 5, 2026 | Chapman Steven Leonard · director, officer: CEO AND PRESIDENT | Sale | 70 | $261 |
| Aug 5, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,233 | $268 |
| Aug 5, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 300 | $260 |
| Aug 5, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 128 | $269 |
| Aug 5, 2026 | Brophy Michael Burkes · officer: CHIEF FINANCIAL OFFICER | Sale | 317 | $268 |
| Aug 5, 2026 | Brophy Michael Burkes · officer: CHIEF FINANCIAL OFFICER | Sale | 478 | $274 |
| Aug 5, 2026 | Moshkevich Solomon · officer: PRESIDENT, CLINICALDIAGNOSTICS | Sale | 200 | $261 |
| Aug 5, 2026 | Chapman Steven Leonard · director, officer: CEO AND PRESIDENT | Sale | 160 | $260 |
| Aug 5, 2026 | Chapman Steven Leonard · director, officer: CEO AND PRESIDENT | Sale | 296 | $267 |
Institutional positioning
13F filings over the trailing two quarters
New 256Increased 649Reduced 524Sold out 68
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JPMORGAN CHASE & CO | Increased | 13,386,667 | May 13, 2026 |
| JPMORGAN CHASE & CO | Reduced | 12,865,346 | Aug 12, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 12,184,876 | May 15, 2026 |
| BlackRock, Inc. | Increased | 10,914,608 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 10,677,338 | May 13, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 9,021,895 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 6,228,216 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 6,008,496 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 5,782,640 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 5,644,695 | May 8, 2026 |
| FMR LLC | Increased | 5,451,396 | Aug 13, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 4,768,593 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 4,040,738 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 3,655,618 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 3,417,472 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026